Introduction
Chronic obstructive pulmonary disease is a major cause of morbidity, disability and mortality in old age. [1] [2] [3] The disease is characterized by shortness of breath, impaired ventilatory function and easy fatiguability. These are the most distressing and disabling symptoms of COPD, limiting exercise tolerance, interfering with basic activities of daily living and often, in turn, impairing quality of life. [4] [5] [6] Community surveys in the United Kingdom have reported the prevalence of respiratory symptoms as a potential cause for significant disability in old age at between 30% and 60%. [7] [8] Others argue that respiratory symptoms are under-recognized in elderly people, 9 in whom respiratory conditions are often asymptomatic in their presentation. However, despite this, elderly community-dwellers cite chest problems as a cause of severe disability second only to musculoskeletal disorders. 10 COPD is a primary cause of death in all age-groups in the UK and four-fifths of all deaths due to COPD occur in individuals aged 70 or older. 2 It is ranked as the fourth leading cause of death in the US. 11 The impact of respiratory symptoms on elderly people is complex and affects different aspects of an individual's life. Psychological status plays an important role in maintaining independence in old age. 12 Undiagnosed and untreated anxiety and depressive symptoms may relate to physical disability, impaired quality of life and increased health care utilization. [13] [14] They may also interfere with compliance with medical treatment and accelerate mortality. 13, 15, 16 Chronic obstructive pulmonary disease in old age may have a devastating effect. The disease progresses in a subtle way and may gradually incapacitate the patient to a level of dependence in daily activities.
Prevalence of depression and anxiety in elderly patients with COPD
The current review provided the opportunity to conduct a meta-analysis of studies of anxiety and depression in elderly patients with COPD. The aims of this review were to estimate the prevalence of depression and anxiety symptoms and to investigate the consequences in patients with chronic obstructive pulmonary disease. Electronic searches were performed for English citations using the databases, Medline (1966 Medline ( -1998 , Psychlit (1984 Psychlit ( -1998 and Cinhal (1982 Cinhal ( -1998 . The following key words were used: 'COPD', 'depression' and 'anxiety'. The bibliographies of articles so extracted were scrutinized to identify other potentially relevant articles.
Studies were included in the analysis, provided that they included patients with chronic obstructive pulmonary disease as the principal diagnosis and reported the prevalence of depressive and anxiety symptoms in percentage terms. A number of studies were excluded, as they only reported mean scores of depressive or anxiety symptoms. A standard measure of effect size was calculated for each trial and weighted pooled estimates were obtained to estimate the prevalence of depressive symptoms and anxiety in this patient group.
Eleven studies were identified with a percentage score of depressive symptoms and nine studies Mood disorders in elderly patients with chronic obstructive pulmonary disease with anxiety symptoms. For all studies with depressive or anxiety symptoms, we performed pooled effect-size analysis giving best estimates of prevalence of depression or anxiety (95% confidence limits). The total population studied comprised 900 subjects; the best estimate of prevalence of depression was 40% (36-44 %), and for anxiety symptoms (total population 539), 36% (31-41%).
Thus in the meta-analysis, combined effect sizes for depressive and anxiety symptoms were very high in this patient group (Table 1) and comparable to those in idiopathic Parkinson's disease or brain damage due to stroke. 29, 30 However, none of the articles reviewed gave details of the effects of treatment on these symptoms. Furthermore, the methodological variation, different assessment tools used and differences in sample populations in the studies examined is acknowledged. Recently van Ede et al. 31 has addressed these issues in a review which included the articles in this metaanalysis.
In the analysis, most of the studies used screening tools (rather than diagnostic instruments), except two which employed a psychiatric interview using DSM III-R criteria (of the American Psychiatric Association) ( Table 1) . Screening questionnaires provide an estimate of the prevalence of depressive symptoms and are used to identify potential 'cases' of clinical depression. The prevalence of depressive symptoms in COPD, sufficient to be of clinical importance, range between 7% and 46%, and that of anxiety up to 49% (Table 1) .
If the problem is so great, why is it often undiagnosed and untreated? Firstly, screening tools for depression or anxiety symptoms are not routinely used in clinical practice. Secondly, symptoms of depression and anxiety in patients with COPD might be masked by physical symptoms, such as decrease in exercise tolerance, breathlessness, fatigue and increased dependence in daily activities. Furthermore, in patients with COPD, poor health, bouts of chest infection and frequent episodes of hospital admission are so common as to be an almost accepted scenario for many patients. In this context, patients may not disclose symptoms of depression or anxiety unless they are specifically asked. 32 Other contributory factors might be that not all physicians are confident enough to pursue psychiatric assessment and patients may fear approaching their physicians because of the stigma of mental illness. Lack of public awareness fuels this stigma, 33 and depression itself is associated with its own specific stigma.
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The interaction of psychiatric symptoms and COPD It has been suggested that untreated depression may interfere with medical treatment and in turn increase health and social service care utilization, leading to higher mortality in the initial phase of hospitalization. 15 Identification of clinical depression or anxiety thus becomes important in itself. Identification is also needed for optimal management of the older patient with COPD.
Because of the chronic nature of their illness, elderly COPD patients are prone to chest infections, and these and other exacerbations are a cause of frequent hospitalization. Although the effect of this may be difficult to quantify, these are clearly adverse events and impair patients' confidence in their ability to manage their illness, which, in turn, may subsequently produce or exacerbate depressive symptoms. 35 Previous studies suggest that patients with COPD suffer from disease-related, high 'emotional stress', leading to behavioural changes, such as increased irritability and social withdrawal. [36] [37] [38] Patients tend to employ psychological mechanisms, such as denial or rationalization, to cope and these too may lead to maladaptive behaviour, such as the refusal to go to hospital during an exacerbation. They may also come to fear that any activity will trigger worsening of their breathing difficulties to the point where participation in social activities is completely and irrationally avoided. Thus independence decreases and is replaced by a growing dependence on medical care.
Discrepancy in the reported rates of depressive symptoms
The lowest prevalence of depressive symptoms was identified by Engstrom et al. 25 at 7% and the highest was in our own studies, 19 at 46%. This huge reported discrepancy may be partly explained by the age group of subjects studied. In the former, the age range was 40-75 (mean 64) years, and statistically there was no difference in the prevalence of depressive symptoms compared to age-sex-matched controls. However, our own studies investigated older COPD patients aged 70-93 (mean 78) years, and also employed two age-sex-matched control groups in whom the prevalence of depressive symptoms was 26% (for disabled controls) and 11% (for normal controls). However, other studies 17, 18 have reported a 42% prevalence of depression in younger COPD patients, suggesting that age per se is not the main factor accounting for these differences. Other areas thus need exploration, for example, the socio-economic status of the subjects and the validity of the assessment tools used.
Two studies reported that in old age, women tend to report less life satisfaction and higher level of depressive symptoms than men. 26, 39 This may be explained by the greater role loss in women compared to men, when disabled by COPD. Traditionally, women are expected to be homemak- ers, care for the family and be responsible for a larger proportion of domestic activities, all of which are severely undermined by COPD. The possible differential effects of gender need to be borne in mind.
Comparisons of depressive symptoms associated with other chronic diseases
Depression is a common problem for older people. The prevalence of the illness is approximately 10% for those who are aged above 65. 40, 41 However, for patients who are hospitalized with acute medical conditions, the prevalence ranges from 10% to 45%. 32 In the current meta-analysis, the prevalence of depressive symptoms (40%) is similar to that reported in other chronic diseases, such as idiopathic Parkinson's disease (about 40%), 29 and higher than that reported in coronary heart disease (25%). 42 In studies comparing emotional distress in COPD patients with that of patients with other chronic illnesses, patients with COPD more commonly tend to report feelings of uselessness, loss of social role and decreased libido. 36, 43 Schlenk et al. 44 investigated six chronic diseases (urinary incontinence, prostate cancer, acquired immune deficiency syndrome, fibromyalgia, hyper-lipidaemia and COPD), and assessed their impact on quality of life, using the Medical Outcomes Study Short Form-36. In this study, COPD subjects had the lowest quality of life in the domains of rolephysical, role-emotional and mental health.
Role loss and what to do with their time is a big problem for many older COPD subjects. Dyspnoea on exertion is the main problem causing subjects to divert their attention towards sedentary activities. In severe hypoxaemic subjects sedentary and more 'intellectual' pursuits may also become a problem because of impaired concentration and mental processing related to hypoxaemia.
Factors that might be associated with depressive symptoms in COPD
The causes of depressive symptoms in COPD patients are complex. In moderate to severe hypoxemic COPD patients, depressive symptoms seem to be associated with age and low socio-economic status 18 and closely associated with the degree of physical disability and impairment of quality of life. 19 Hypoxaemia itself is also associated with impaired quality of life. 45 The onset of depression has been identified as a risk factor for developing cognitive decline in hypoxaemic COPD patients. 46 The use of life-prolonging long-term oxygen therapy (LTOT) in the chronic hypoxaemia of COPD may have major implications for patients' everyday life. Some patients feel tied to the oxygen apparatus and become restricted not only outside, but even within the home. Although studies have investigated the efficacy of oxygen therapy in improving functional performance and quality of life, they have not generally addressed psychosocial implications. The recent findings by Monso et al. 47 confirm that long-term oxygen users suffer severe quality of life impairment and are prone to emotional lability and social isolation. Interestingly, Strom 48 recently identified that, in male and female patients who use oral corticosteroids with long-term oxygen therapy, women are more susceptible than men to frequent hospitalization and early death.
Are intervention strategies effective in treating anxiety and depressive symptoms?

Pulmonary rehabilitation
The British Thoracic Society (BTS) and American Thoracic Society (ATS) guidelines 11, 49 emphasize the need for pulmonary rehabilitation of COPD patients to enhance general wellbeing, improve quality of life and improve independence. Several randomized controlled trials in inpatient and outpatient pulmonary rehabilitation programmes have reported significant improvements in quality of life, reduced symptoms of dyspnoea and increased exercise tolerance. [50] [51] [52] However, very few studies have reported even a meagre improvement in symptoms of anxiety and depression. 22, 55 Possible explanations for this discrepancy include the difficulties of using screening questionnaires (not validated in this patient group) and variability in cut-off points to diagnose a case of depression or anxiety.
Even if they identify depressive symptoms, screening instruments may not be sufficiently sensitive to detect subtle changes during rehabilitation programmes, therefore designing and validating disease-specific scales is worthwhile.
Psychotherapy and cognitive behavioural therapy
Eiser et al. 21 conducted a six-week psychotherapy programme led by a psychiatrist and revealed significant improvement in exercise tolerance but no change in anxiety or depressive symptoms. The programme was aimed at disentangling the root cause(s) of anxiety symptoms from the coping strategies used to overcome problems. Others have claimed success for psychotherapy and relaxation therapy in improving dyspnoea and anxiety symptoms in COPD. 53, 54 It is difficult to determine whether positive effects are specifically due to the type and content of therapy or because of simpler explanations, such as the use of relaxation, or because patients received attention. However, Emery et al. 55 in three groups of COPD patients, compared the efficacy of (1) exercise training combined with psychotherapy and education (2) education and psychotherapy and (3) education alone. Their findings suggest that those in the first group showed significant improvement in endurance, reduced anxiety and increased cognitive performance, with no improvement observed in the other two groups.
Psycho-education
A recent meta-analysis by Devine and Pearcy 56 examined the benefits of psycho-education (exercise training accompanied by education and psychosocial support) in COPD. In seven studies they observed significant improvement in endurance, functional status and psychological wellbeing. In other studies, intensive education for COPD patients has led to significant reduction in health care utilization and also increased knowledge about self-management of the disease, 57 for example, early patient self-referral to GPs or hospital before the acute exacerbation reaches a severe condition. Others have suggested controlling factors that may trigger acute exacerbation may reduce hospital admission and improve quality of life. 58 A very recent study by Gallefoss et al. 59 compared patient education of asthmatic and COPD patients. Their findings suggest that education led to significant improvement in quality of life and forced expiratory volume in asthmatic patients, but not in COPD patients. Caution is needed in interpreting the result of this study, as there was wide variation in the age group of the subjects (that of COPD subjects was 57 years, c.f. 41 years for asthmatics). Furthermore, the COPD patients had a longer duration of illness (median 15 years, cf. seven years for asthmatics) and the improvement in FEV 1 in the asthmatic group suggests poor control of disease prior to inclusion in the study.
Antidepressant use in COPD patients
The literature is sparse regarding the use of antidepressants in COPD. Two studies have attempted to examine the efficacy of antidepressants in COPD patients and both were inconclusive. Previously, in a double-blind crossover study, Gordon et al. 60 compared the efficacy of desipramine with that of placebo in younger age-range COPD patients (N=13, mean age 63 years), with the finding that desipramine was poorly tolerated in this patient group. In this study, seven of the subjects withdrew due to acute exacerbations, side-effects (dry mouth, sleep disturbance, urinary retention, fatigue and tremor) and other concomitant medical problems. Koenig et al. 61 in a study of medically ill patients had difficulties recruiting subjects because of medical contraindications, such as delirium, bladder outlet obstruction, severity of the overall illness, cancer and patient refusals.
Recently, in this department, the feasibility of using the SSRI fluoxetine in elderly COPD patients has been investigated. Fluoxetine is recognized to be effective and well-tolerated in frail ill elderly Table 2 . Side-effects reported by COPD patients taking fluoxetine
• Nausea • General tiredness • Loss of weight • Tremor • Dizziness • Anxiety • Marked irritability towards family problems people. 2 We recruited 14 elderly COPD patients in an open, single-blinded study of 20mg/day fluoxetine therapy for six months. 63 Of these, seven subjects did not complete the study. Five of the subjects withdrew because of side-effects (Table  2) , one due to family problems and one patient died of a cause unrelated to antidepressants.
However, perhaps the most important finding of this pilot study was the reluctance of patients, identified as depressed by a well-validated psychiatric tool, the Geriatric Mental Status Schedule, 64 to accept treatment with fluoxetine. Seventy per cent of depressed patients (N=57) refused antidepressant treatment, the common reasons for refusal being fear of side-effects, embarrassment, denial of depression, worries about addiction and a frustration with taking 'too many drugs'. Reluctance to accept either the diagnosis or treatment for depression has been previously reported in elderly patients with depression associated with other chronic medical conditions.
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Psychiatric co-morbidity (depression plus anxiety) in COPD
Depressive and anxiety symptoms are common in COPD patients (Table 1) . These studies, however, did not investigate the overlap between anxiety and depressive symptoms. In a pilot investigation in this department, 65 the overlap of anxiety symptoms with depression in elderly patients with COPD was further explored. In the same group of depressed elderly COPD patients (N=57) described above, the prevalence of anxiety symptoms was found to be 34%, whereas in nondepressed patients (N=80), it was only 5%. This suggests a striking association between symptoms of depression and anxiety. Caution is needed in the interpretation of these findings, not least because the subjects studied were residents of the inner city, where socio-economic problems are often prevalent. Furthermore, this cross-sectional study cannot say to what extent the anxiety and depressive symptoms arose simultaneously or were sequential, with one disorder secondary to the other. 66 A longitudinal study is therefore worth consideration.
Many studies have reported 18, 36, 37, 67 that anxiety and depressive symptoms are better predictors of quality of life than lung function parameters. Depression is associated with reduced social interaction and role functioning. 38, 43 Other studies have identified physical disability associated with depressive symptoms. 18, 19, 20 Further, findings by Wells et al. 68 confirm that depressive symptoms are related to subjects' functional wellbeing. It is a common clinical scenario that many COPD patients present with sleep disturbance, reduced energy level, difficulties in performing daily activities and reduced social interaction. Attributing such symptoms purely to COPD may mean that the diagnosis of depression is overlooked. 19 A standard clinical interview will often fail to identify depression in chronic medical illness: the use of a psychiatric screening questionnaire in these circumstances is strongly recommended.
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Depression in COPD and carers
Keele-Card et al. 69 examined loneliness and depression in a sample of 30 COPD patients and their spouses. Their findings suggest that there was no difference in mean scores of loneliness and depression between the two groups. Similar findings were reported by Meara et al., 70 who studied the prevalence of depression in elderly Parkinson's patients (64%), their spouses and carers (34%). In a community survey, Livingston et al. 71 compared the prevalence of depressive symptoms in carers with that in co-residents of elderly people with dementia, depression or physical disability. Their findings revealed a higher prevalence of depressive symptoms in carers than in co-residents (24% c.f. 11%, p < 0.05) and that symptoms were most common in women caring for dementia patients. Similar findings have also been observed in carers of stroke patients. 72 Depression in a patient with COPD may trigger depression in a carer but the reverse may also be true. For example, in prognostic studies of depression in psychiatric practice, depression in a carer is strongly correlated with poor outcome, 73 and the belief by a carer that a depressed person is 'putting it on' also has a major negative effect on the outcome of depression. 74 These findings have not been reproduced in patients with physical disability such as COPD, but there seems little reason to deny the existence of a 'vicious circle' in this patient group as well.
Interestingly, the present research 67 has suggested that elderly subjects with COPD who live alone seem better satisfied with their lives than those who live with their spouses or relatives. This may however have been a survival or migration effect, those with more severe illness needing con-tinued help from 'live-in' carers. Although psychosocial support plays an important role in the ability of COPD patients to maintain independent living, this may depend on the quality rather than the quantity of support available. Moreover, COPD patients may have a wider range of needs, some of which may be complex, as the illness affects various aspects of their lives in its progression. Psychosocial factors, such as a poor relationship with one's spouse, have been implicated in the prognosis of depression in old age. 75 Rehabilitation programmes should address these issues.
The wellbeing of carers is vitally important and can influence the carer's ability to provide care. For health care professionals planning long-term strategies for their patients, the welfare of the carers should be considered in terms of respite care or support in the community, and carer (as well as patient) education.
Health-care utilization in depressed patients with COPD
Poor general health, exacerbation and frequent hospitalization is the fate of many COPD patients. Retrospective uncontrolled studies suggest that health care utilization in depressed patients is far higher than that in non-depressed patients. 65 These findings merely suggest that depression is associated with longer treatment spells in the hospital after recovering from acute exacerbations, but do not tell us what other factors might be associated with delayed discharge. Regueiro et al. 76 carried out an extensive study of 866 COPD patients admitted with acute exacerbations. Patients were divided into two groups, to be cared for either by a pulmonologist or a generalist. Their findings suggest no difference between the healthcare costs or survival of the two groups. Prospective controlled studies are required to confirm or refute the effect of emotional status on health-care use in COPD, and to address the value of the multidisciplinary team in supporting and resettling the patient in the community.
Conclusion
Clinical anxiety and depressive symptoms are common in patients with COPD. They are often undiagnosed and untreated in this patient group. Those with depressive symptoms are usually more physically disabled and have greater impairment of their quality of life. This argues for improved detection of depression and for appropriate intervention for anxiety and depressive symptoms in patients with COPD. Such strategies should be multi modal, i.e. involving the physical, psychological and social domains, and should closely involve carers. There has been little evaluation of the treatment of depression associated with COPD.
